Ion coalescence of neutron encoded TMT 10-plex reporter ions.

Isobaric mass tag-based quantitative proteomics strategies such as iTRAQ and TMT utilize reporter ions in the low mass range of tandem MS spectra for relative quantification. The recent extension of TMT multiplexing to 10 conditions has been enabled by utilizing neutron encoded tags with reporter ion m/z differences of 6 mDa. The baseline resolution of these closely spaced tags is possible due to the high resolving power of current day mass spectrometers. In this work we evaluated the performance of the TMT10 isobaric mass tags on the Q Exactive Orbitrap mass spectrometers for the first time and demonstrated comparable quantification accuracy and precision to what can be achieved on the Orbitrap Elite mass spectrometers. However, we discovered, upon analysis of complex proteomics samples on the Q Exactive Orbitrap mass spectrometers, that the proximate TMT10 reporter ion pairs become prone to coalescence. The fusion of the different reporter ion signals into a single measurable entity has a detrimental effect on peptide and protein quantification. We established that the main reason for coalescence is the commonly accepted maximum ion target for MS2 spectra of 1e6 on the Q Exactive instruments. The coalescence artifact was completely removed by lowering the maximum ion target for MS2 spectra from 1e6 to 2e5 without any losses in identification depth or quantification quality of proteins.

[1]  M. Gorshkov,et al.  Observation of ion coalescence in Orbitrap Fourier transform mass spectrometry. , 2012, Rapid communications in mass spectrometry : RCM.

[2]  Manor Askenazi,et al.  Delayed fragmentation and optimized isolation width settings for improvement of protein identification and accuracy of isobaric mass tag quantification on Orbitrap-type mass spectrometers. , 2011, Analytical chemistry.

[3]  Ruedi Aebersold,et al.  Quantitative analysis of protein complex constituents and their phosphorylation states on a LTQ-Orbitrap instrument. , 2010, Journal of proteome research.

[4]  Frank Fischer,et al.  Targeted data acquisition for improved reproducibility and robustness of proteomic mass spectrometry assays , 2010, Journal of the American Society for Mass Spectrometry.

[5]  M. Selbach,et al.  Global quantification of mammalian gene expression control , 2011, Nature.

[6]  Albert Sickmann,et al.  Precise protein quantification based on peptide quantification using iTRAQ™ , 2007, BMC Bioinformatics.

[7]  Markus Müller,et al.  Quantitative Proteomic Analysis of Protein Complexes , 2008, Molecular & Cellular Proteomics.

[8]  Richard J. Lavallee,et al.  Optimized fast and sensitive acquisition methods for shotgun proteomics on a quadrupole orbitrap mass spectrometer. , 2012, Journal of proteome research.

[9]  G. Drewes,et al.  Affinity profiling of the cellular kinome for the nucleotide cofactors ATP, ADP, and GTP. , 2013, ACS chemical biology.

[10]  P. Grandi,et al.  Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes , 2011, Nature Biotechnology.

[11]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[12]  Jens M. Rick,et al.  Quantitative mass spectrometry in proteomics: a critical review , 2007, Analytical and bioanalytical chemistry.

[13]  Derek J. Bailey,et al.  Amine-reactive Neutron-encoded Labels for Highly Plexed Proteomic Quantitation* , 2013, Molecular & Cellular Proteomics.

[14]  G. Superti-Furga,et al.  Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells , 2009, Leukemia.

[15]  Neutron-Encoded Protein Quantification by Peptide Carbamylation , 2013, Journal of The American Society for Mass Spectrometry.

[16]  G. Drewes,et al.  Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells , 2011, Leukemia.

[17]  B. Kuster,et al.  Ultra‐high intra‐spectrum mass accuracy enables unambiguous identification of fragment reporter ions in isobaric multiplexed quantitative proteomics , 2012, Proteomics.

[18]  Rolf U Halden,et al.  Towards proteome standards: the use of absolute quantitation in high-throughput biomarker discovery. , 2010, Journal of proteomics.

[19]  Michaela Scigelova,et al.  Fourier Transform Mass Spectrometry , 2011, Molecular & Cellular Proteomics.

[20]  M. Gorenstein,et al.  Absolute Quantification of Proteins by LCMSE , 2006, Molecular & Cellular Proteomics.

[21]  M. Bantscheff,et al.  High-resolution enabled TMT 8-plexing. , 2012, Analytical chemistry.

[22]  Forest M White,et al.  Quantitative phosphoproteomic analysis of T cell receptor signaling in diabetes prone and resistant mice. , 2010, Journal of proteome research.

[23]  Ruedi Aebersold,et al.  Targeted proteomic strategy for clinical biomarker discovery , 2009, Molecular oncology.

[24]  Matteo Pellegrini,et al.  Global Phosphoproteomics Reveals Crosstalk Between Bcr-Abl and Negative Feedback Mechanisms Controlling Src Signaling , 2011, Science Signaling.

[25]  N. Gray,et al.  In situ kinase profiling reveals functionally relevant properties of native kinases. , 2011, Chemistry & biology.

[26]  Ping Zhang,et al.  A proteomic approach for plasma biomarker discovery with 8-plex iTRAQ labeling and SCX-LC-MS/MS , 2010, Molecular and Cellular Biochemistry.

[27]  G. Mazzucchelli,et al.  Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues. , 2011, Journal of proteome research.

[28]  Andrew H. Thompson,et al.  Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. , 2003, Analytical chemistry.

[29]  M. Mann,et al.  Proteomic workflow for analysis of archival formalin‐fixed and paraffin‐embedded clinical samples to a depth of 10 000 proteins , 2013, Proteomics. Clinical applications.

[30]  Albert J R Heck,et al.  Revealing promiscuous drug-target interactions by chemical proteomics. , 2009, Drug discovery today.

[31]  B. Kuster,et al.  Characterization of a high field Orbitrap mass spectrometer for proteome analysis , 2013, Proteomics.

[32]  M. Bhasin,et al.  Optimizing a Proteomics Platform for Urine Biomarker Discovery* , 2010, Molecular & Cellular Proteomics.

[33]  Derek J. Bailey,et al.  Neutron-encoded mass signatures for multi-plexed proteome quantification , 2013, Nature Methods.

[34]  Bernhard Kuster,et al.  Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors , 2007, Nature Biotechnology.

[35]  Edward L. Huttlin,et al.  Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. , 2012, Analytical chemistry.

[36]  Bernhard Kuster,et al.  Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present , 2012, Analytical and Bioanalytical Chemistry.

[37]  Martin Kircher,et al.  Deep proteome and transcriptome mapping of a human cancer cell line , 2011, Molecular systems biology.

[38]  D. Hochstrasser,et al.  Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. , 2008, Analytical chemistry.

[39]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[40]  J. Ellenberg,et al.  The quantitative proteome of a human cell line , 2011, Molecular systems biology.

[41]  B. Kuster,et al.  Measuring and managing ratio compression for accurate iTRAQ/TMT quantification. , 2013, Journal of proteome research.

[42]  E. Nikolaev,et al.  Theory of peak coalescence in Fourier transform ion cyclotron resonance mass spectrometry. , 2009, Rapid communications in mass spectrometry : RCM.